Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

IB Acquisition Corp.

NASDAQ: IBAC · Industrial Applications and Services · 5 alerts · CIK 1998781

Share price
$10.85Close, Nov 16
Market cap
$54.3M
Shares outstanding
5.01MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Commercial Physical & Biological ResearchSIC 8731

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All IB Acquisition Corp. filings on SEC EDGAR ↗

4:15 PM ET 8-K
Shareholder Meeting

IB Acquisition Shareholder Meeting

IB Acquisition Corp. has scheduled its 2026 Annual Meeting of Stockholders for December 16, 2026, with a record date of October 28, 2026. The meeting is intended to help the company regain compliance with Nasdaq Listing Rule 5620(a) following a deficiency notice for failing to hold an annual meeting within twelve months of its fiscal year end. The company also established an October 26, 2026 deadline for stockholder proposals to be included in the proxy materials.

5:15 PM ET 8-K
Nasdaq/NYSE Compliance Notice

IB Acquisition Nasdaq/NYSE Compliance Notice

IB Acquisition Corp. received a deficiency notice from Nasdaq on October 5, 2026, for failing to hold an annual meeting of shareholders within twelve months of its fiscal year end. The company has 45 days to submit a compliance plan and could be granted an extension until March 29, 2027, to regain compliance. The notice has no immediate effect on the listing or trading of the company's common stock (IBAC).

Counterparty
Nasdaq
Term
until March 29, 2027
6:01 AM ET 8-K
Other 8-K Filing

IB Acquisition Other 8-K Filing

IB Acquisition Corp. (IBAC) held a special meeting where stockholders approved an extension to the deadline for completing its initial business combination from September 28, 2026, to March 28, 2027. The company filed a charter amendment to formalize this extension and updated its trust agreement to reflect the new liquidation and redemption timeline.

Term
6 months
5:16 PM ET 8-K/A
Other 8-K Filing

IB Acquisition Other 8-K Filing

IB Acquisition Corp. entered into a $50.0 million Equity Purchase Facility Agreement with an institutional investor in connection with its pending business combination with GNQ Insilico, Inc. The agreement establishes a facility where the company may sell shares from time to time following the merger, but no shares have been sold as of the filing date.

Counterparty
GNQ Insilico, Inc.
Term
36 months
5:04 PM ET 8-K
M&A Deal

IB Acquisition Signs $50M M&A Deal with GNQ Insilico, Inc.

IB Acquisition Corp. entered into a $50 million equity purchase facility with an institutional investor to provide capital following its pending business combination with GNQ Insilico, Inc. The facility allows the company to sell shares of Class A common stock over a 36-month period to support the post-merger entity, which will trade under the symbol GNQI.

Value
$50M
Counterparty
GNQ Insilico, Inc.
Term
36 months

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.